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ABSTRACT 
 
Depression leads to substantial morbidity and mortality on a global scale, but it is 
frequently underrecognized and inadequately treated in primary care settings. The 
detection of depression is particularly challenging in under-resourced countries. This 
study attempts to determine rates of recognition and treatment of depressive disorders at a 
community clinic in the Cape Flats, South Africa. 
The diagnostic instrument PRIME-MD was administered and charts reviewed for 
a sample of 222 patients presenting to the Lotus River Community Health Centre. 
Outcomes sought were (1) the prevalence of depressive disorders and (2) rates of 
detection and treatment as indicated by antidepressant prescription through chart review.  
 The prevalence of depressive disorders in the group was found to be 32% (N=70), 
with 13% meeting criteria for major depressive disorder (N=29). Depressed patients 
tended to be younger (p<.001) and female (p=.026) and were more likely to describe 
somatic symptoms than were non depressed (p<.001). There was a statistically significant 
correlation between a diagnosis of depression and prescription of a tricyclic 
antidepressant (TCA) (p=.028). The sensitivity and specificity of a TCA prescription for 
depression were 20% and 91%, respectively. Multiple logistic regression analysis 
demonstrated that the strongest factor contributing to either a diagnosis of depression or a 
prescription of an antidepressant was the presence of somatic complaints.  
In this primary care setting, patients with depressive diagnoses were reliably 
recognized as indicated by a significant correlation between depression and 
antidepressant receipt. Physicians appeared to respond primarily to somatic rather than 
psychological presentations. While depressed patients received antidepressants more 
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frequently than non-depressed, only a minority of depressed patients was recognized as 
such. Analyzing patterns of recognition requires an understanding not only of physician 
practices but also of the cultural setting of the health care system.  
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INTRODUCTION 
 
Context 
 Mental health disorders significantly impact the health and well being of 
individuals and communities on a global scale. Of the myriad conditions that comprise 
this group of disorders – substance dependence, mood disorders, psychoses, PTSD, to 
name a few – depressive disorders are unique in that they develop insidiously yet 
dramatically affect morbidity and may affect mortality. While many developed countries 
have acknowledged the importance of depression through research and policy 
discussions, problems of adequate recognition and appropriate treatment persist. 
Recently, global discourse has increasingly emphasized mental health – and depression in 
particular – as a formidable health challenge, and both international agencies and 
individual countries are mobilizing political and financial resources to confront the issue. 
In addition to obstacles of detection well documented by western practitioners, health 
care providers in many developing countries face further barriers: cultural differences, 
political apathy, lack of resources, and a paucity of research in the field. Determining 
whether global solutions parallel those of the west will entail a detailed analysis of global 
mental health epidemiology in the context of diverse health care delivery systems. This 
study will begin to address such issues for a community clinic in South Africa. 
 
Definitions 
 The hallmark of depressive disorders is a change in mood or affect that causes 
intense emotional suffering and disrupts the rhythm of daily life. Patients with mood 
disorders can experience a spectrum of symptoms including decreased pleasure in life’s 
activities, changes in sleep, energy, and appetite, and feelings of guilt or worthlessness. 
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The most severe consequence of depression is suicide, and as many as 15% of individuals 
with major depression are victims of this outcome.1 Psychological symptoms represent 
the most common presentation of depression, but many patients experience the disease as 
a cluster of somatic symptoms such as chronic pain, fatigue, and headaches that often 
masks as a physical disorder. 
 Although patients can experience a single episode, most mood disorders are 
recurrent, and in some patients depressed periods alternate with manic periods (bipolar 
illness).  Relapse after treatment is common, and long-term attention to the depressed 
patient is essential. The origins of depression are both genetic and social. Patients who 
have endured traumatic childhood experiences are more vulnerable to depression, and 
depression is 1.5 to 3 times more common in biological relatives.1 In addition, episodes 
of major depression are often triggered by severe psychosocial stressors.  
 Mood disorders encompass several discrete clinical entities. Major depressive 
disorder (MDD) is considered by some to be the most debilitating and is the subject of 
the majority of research in the field. Its average age of onset is mid-20s. As outlined by 
the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), 
major depression is a clinical diagnosis defined by the presence of five out of nine 
characteristic symptoms listed below: 
1) Sadness or depressed mood 
2) Anhedonia (diminished interest in daily life) 
3) Disturbances in sleep patterns 
4) Loss of energy 
5) Changes in appetite 
6) Feelings of worthlessness of self blame 
7) Difficulty concentrating 
8) Psychomotor retardation or agitation 
9) Suicidal ideation 
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Diagnostic criteria for major depression indicate that either depressed mood or anhedonia 
must be present as one of the five symptoms. 
 Specific mood disorders also differ according to the number and time course of 
symptoms. Patients with partial remission of a major depressive disorder, as its name 
implies, do not meet criteria for major depression but have experienced an episode in the 
past from which they have not fully recovered. Dysthymia is a chronic disorder 
characterized by depressed mood more often than not over a period of at least two years’ 
duration and is differentiated from major depression by its severity, chronicity, and 
persistence. Mood alteration in dysthymia negatively impacts work or social functioning. 
While chronic in nature, dysthymia is no less debilitating than other mood disorders. It is 
thought that approximately 10% of dysthymic patients will have a first episode of major 
depression each year.1 
A patient who presents with a two-week period of depressed mood or anhedonia 
and at least two of the criteria for major depression is classified as having minor 
depressive disorder, or depressive disorder not otherwise specified (NOS). Of note, the 
terms “major” and “minor” implicated in depressive disorders refer only to the number of 
depressive symptoms experienced and do not reflect the severity of the disorder or the 
degree of impact on functioning.2 Finally, a diagnosis of bipolar disorder indicates that 
the patient experiences both depressive episodes as well as manic episodes characterized 
by elation, over activity, and blunting of normal inhibitions. 
 Treatment of depression involves either pharmacological agents or 
psychotherapy, which have proven to be effective independently or in concert. 
Antidepressant classes frequently used in the treatment of depression include the 
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selective serotonin reuptake inhibitor (SSRIs) and the tricyclic antidepressants (TCAs). 
Tricyclics represent the older class of antidepressants and include such drugs as 
amitriptyline and imipramine. Pharmacological agents in this class are thought to be 
effective at doses ranging from 125 to 150 mg per day, although anecdotal evidence 
suggests that lower doses might be efficacious. Side effects of TCAs include 
anticholinergic effects, sedation, lowered seizure threshold, and prolonged QT interval, 
and overdose can be fatal. TCAs and SSRIs are thought to be equivalent in efficacy, but 
physicians often choose to prescribe SSRIs if available because of a less severe side 
effect profile and consequently increased tolerability.3  
While this study focused on depressive disorders in primary care, an 
understanding of psychiatric illnesses that often coexist or co-present with depression is 
instructive. Generalized anxiety disorder is characterized by persistent and excessive 
worry for a period of at least 6 months with at least three other related symptoms. 
Patients with anxiety disorder NOS exhibit prominent anxiety or phobic avoidance but 
fail to meet criteria for another anxiety disorder. Patients with somatoform disorders 
display physical symptoms suggestive of a general medical condition but not fully 
explained by one; the symptoms must cause significant distress or functional impairment. 
Multisomatoform disorder and somatoform NOS are differentiated by the duration of 
symptoms.1  
While these specific criteria are useful to form a common understanding of 
depression across different health care settings and cultures, many health care 
practitioners invoke a broader definition of mental health. One chronicle describes a 
requirement for positive symptoms:  “Mental health is not simply the absence of 
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detectable mental disease but a state of well-being in which the individual realizes his or 
her own abilities, can work productively and fruitfully, and is able to contribute to his or 
her community.”4 An account of South Africa’s mental health care policy conceptualizes 
mental health as the promotion of psychosocial well-being.5 And the World Health 
Organization (WHO) constitution defines mental health as a “state of complete physical, 
mental, and social well-being.”6 Because most research focuses on the narrowest 
definitions of mental health, it is likely that the scope of the problem is far broader than 
suggested by statistics. 
 
Epidemiology 
 Depression is widespread across many health care settings and populations. 
Prevalence rates of major depression in the United States are 10% in a one-year period 
and 17% over the course of a lifetime.7 Community samples have shown point prevalence 
that ranges from 5% to 9% for women and 2% to 3% for men.1 Investigators from a rural 
primary care practice found 10% to have depressive disorders and another 11.2% to have 
significant depressive symptoms without a clear diagnosis.8 Another study showed that 
the prevalence of depression increases with higher levels of medical care. It is estimated 
that as much as 4% of the general population, 10% of primary care patients, and 14% of 
medical inpatients in the United States are affected by major depression.9 Of cases of 
major depression, 20% are documented as severe.7  
 On an international scale, prevalence estimates of depression are consistently 
high, varying with location and study design. One review of international studies found 
that the prevalence of psychiatric disorders ranged from 17% to 24% of the general 
population.10 A cross-cultural study conducted by WHO at 14 global sites found a 
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composite depression prevalence of 10.4%.6 Specific studies confirm that depression is a 
common disorder across national boundaries. In Soweto, Johannesburg investigators in 
one primary care clinic found the overall prevalence of alcohol, depressive, anxiety, and 
adjustment disorders to be 14.38%.11 In a group of Zimbabwean township women, 30.8% 
had experienced a depressive or anxiety disorder during the previous year.12 A 
community study of minor psychiatric morbidity in Taiwan found prevalence rates of 
18% for men and 33.3% for women.13 Evidence indicates that depression rates have been 
increasing in past decades in the United States, Western Europe, Puerto Rico, Lebanon, 
and Taiwan.14 
Depression also disproportionately affects certain demographic groups. 
Adolescent and adult women traditionally show higher rates of major depression than 
men, with a one-year American prevalence of 12%, versus 8% for men.7 Lifetime risk for 
major depression in community samples is also significantly higher for women (10% to 
25%) than for men (5% to 12%).1 In addition, many studies have found that major 
depression increases with age.15 
Although the DSM-IV states that the prevalence of major depression is thought to 
be unrelated to ethnicity, education, income, or marital status, individual studies have 
found variation in rates based on several of these factors. A community-based South 
African study identified six factors that correlated with depression: gender, age, marital 
status, employment, poverty, and education.16 Minor depression was more common in 
Taiwan among women over 35, unemployed men, and individuals of a lower 
socioeconomic status.13 A community survey in Pakistan found that increased age, less 
education, and social disadvantage were associated with psychiatric disorders and 
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emotional stress.17 Results from the National Comorbidity Survey revealed that 
depression prevalence was higher in females, young adults, and those with less than a 
college education.18 Finally, a WHO report suggested that the course of depressive 
disorders is altered depending on socioeconomic status, likely because of decreased 
access to care.6 
Depression is associated with significant medical and psychiatric comorbidities. 
As many as a quarter of patients with general medical conditions such as diabetes or 
cardiac disease will develop major depression during the course of their illness. The 
disorders are mutually reinforcing; the prognosis of medical illness is less favorable in 
the presence of depression, and depressive episodes are longer and less responsive to 
treatment with concurrent medical illness.1 It is estimated that two-thirds of patients who 
are depressed also meet criteria for an anxiety disorder, and there is in fact a diagnosis 
called mixed anxiety-depressive disorder. A study in Zimbabwe found that 65% of 
women with depression also had anxiety features.12 Conversely, one study found that 
nearly 90% of patients with generalized anxiety disorder were concurrently diagnosed 
with major depression or dysthymia.16 
 
Burden of disease 
 Untreated depressive disorders have been shown to result in substantial disability. 
Numerous studies show that patients who suffer from major depression experience more 
functional impairment in daily living than those who do not. One study of three U.S. 
health care provision systems found that patients with either a depressive disorder or 
depressive symptoms demonstrated worse physical and social functioning, worse 
perceived current health, and more bodily pain than did patients without chronic medical 
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conditions. Furthermore, this impairment was comparable to that associated with major 
chronic medical conditions such as hypertension, diabetes, coronary artery disease, and 
arthritis.19 
On a global scale, mental health disorders are equally disabling. Depression 
affects 340 million people, and one in four individuals will suffer from a mental health or 
behavioral disorder in his or her lifetime.6 Moreover, five of the ten leading causes of 
disability worldwide are psychiatric, with major depression ranking fourth.20 Depression 
is the leading cause of disability worldwide in the 15 to 44 year age group, and experts 
predict that by 2020 it will be the second leading cause of all disability.6 Of the one 
million annual deaths attributable to suicide worldwide, it is likely that half are propelled 
by depression.  
Impact of disease can also be assessed by disability-adjusted life years (DALYs), 
a concept developed to quantify the burden of disease over time and measure the cost 
effectiveness of interventions. One DALY can be thought of as one year of healthy life. 
As of 2000, 12% percent of all lost DALYs was attributable to psychiatric or behavioral 
conditions.6 However, most countries devote less than 1% of government expenditures to 
these problems.6 
It is probable that depression is disabling because its manifestations are so 
intricately related to the activities of daily life. Problems with mood, interest, attention, 
sleep, energy, and appetite adversely impact an individual’s ability to cope in almost any 
setting or relationship. Furthermore, changes in these areas are easily apparent to family, 
coworkers, or teachers. Those who work or live with a patient and do not understand 
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depression might perceive this change of behavior as an inability to cope or to confront 
life’s stresses. Such misunderstanding can ultimately lead to intolerance and stigma.  
In addition to its significant impact on individual functioning, depression is also 
associated with high medical utilization and substantial societal costs. In a study of three 
United States HMOs, it was found that patients with current depression or depression in 
remission had a significantly higher number of office visits and hospital days than non-
depressed patients.21 Furthermore, the health care system incurs costs associated with 
failure to recognize mental disorders in the form of resources spent exploring and treating 
physical symptoms that actually represent psychological diagnoses. Further studies 
demonstrate that cost of depression in the workplace – in terms of lost workdays and 
disability – is greater than that for ischemic heart disease.6 On a global scale, the 
economic costs incurred from health care expenditures, lost productivity, and crime 
secondary to mental illness affects individuals, families, and communities. Statistics 
likely underestimate the actual cost since much of the impact is indirect.6 
While depression clearly affects a large proportion of all populations, the overall 
burden of disease is likely higher than reported. Most prevalence studies focus on major 
depression and do not consider mood disorders such as dysthymia or minor depression 
whose chronicity or severity can render them equally or more debilitating. And the 
number of people who experience depressive symptoms but fall short of meeting the 
criteria for a mood disorder is thought to be magnitudes higher across all settings.  
 
Challenges of recognition 
 Were depression easily recognized, the disability it engenders in its untreated 
form would be lessened. However, depression is often undetected, likely because of a 
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misalignment between the nature of the disorder and the system in place to detect it. 
While depression primarily presents in a primary care setting, most primary health care 
systems are not equipped to see it. Unrecognized depression translates into a missed 
opportunity to intervene and treat the disorder.  
While specialists treat many chronic medical disorders, depressed patients are 
more often cared for in primary care settings than in the mental health sector. In the case 
of depression, it is commonly asserted that half of patients seek help from a primary care 
physician.22, 23 Conversely, it is estimated that a quarter to a third of patients who present 
in a primary care setting have psychological symptoms.8, 24, 25 One study that surveyed 
numerous countries found that in sub-Saharan Africa, Latin America and other countries, 
as many as one-fifth to one-third of patients have depression as the principal or secondary 
reason for seeking primary medical care.26 
 Yet detection rates for depression in primary care are consistently low. Studies 
suggest that between 18% and 50% of depressed patients are recognized as such by their 
primary care providers,27 and that even fewer receive appropriate treatment. One study of 
medical outpatients reported a detection rate of 36% for patients with either major 
depression or dysthymia. In the same study, physicians misdiagnosed nearly twenty 
percent of non-depressed patients with either major depression or dysthymia.28 Another 
study found that detection rates varied according to utilization rate. While 84% of high 
utilizers were accurately identified as depressed, only one third of depressed patients who 
did not frequently visit the clinic were recognized.29 Furthermore, it has been found that 
only a minority of depressed patients receives appropriate treatment.30 The situation is 
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exacerbated in developing countries; in sub-Saharan Africa and in China, treatment rates 
of depression are estimated to be as low as 5%.  
Barriers to the detection of depression can be conceptualized by considering 
causes at the patient, physician, and system level. Patients frequently overlook depressive 
symptoms because they are considered part of normal emotional variability. Furthermore, 
with the exception of suicidal ideation, symptoms of depression are non-specific and are 
not characteristically linked to a certain disease, such as chest pain to a myocardial 
infarction. Patients are also less likely to report psychological symptoms because of the 
stigma frequently associated with mental disorders. The risks of losing employment or 
being barred from insurance coverage are real and often overpower an inclination to 
disclose symptoms.  
 At the physician level, challenges to diagnosing depression include lack of 
training and somatization of disease. Many primary care physicians are deficient in 
knowledge about depression and lack confidence in appropriately treating it. 23 In 
addition, some physicians fail to routinely screen for depression or are reluctant to broach 
the subject since the inquiry might lead to an uncomfortable or lengthy discussion. It has 
been hypothesized that some physicians purposefully avoid the topic of mental health 
because they feel that the resources available would be inadequate to treat the patient 
were positive symptoms or a diagnosis uncovered. 
The diagnosis of depression is also complicated by the fact that many depressed 
patients present with somatic rather than psychological complaints. Studies have shown 
that when depression presents as physical symptoms, it is less likely to be recognized and 
treated appropriately. The somatic presentation of depression is subtle. Symptoms such as 
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pain, nausea, and headache do not fit the traditional conception of depression and are 
difficult to identify as such if not actively sought. The somatization of depression is also 
problematic because somatic symptoms are non-specific and are often linked to medical – 
rather than psychiatric – disorders. Physicians are trained to reflexively pursue a rule-out 
myocardial infarction workup for chest pain or to evaluate the potentially serious medical 
causes of headache. Such workup is appropriate but distracts from the possibility of other 
etiologies. 
 Barriers to diagnosing depression also occur at the level of health care delivery 
systems. The most commonly cited challenge to the diagnosis of depression is limited 
time during the patient encounter. Since depression is a clinical diagnosis that cannot be 
confirmed with a simple exam or laboratory test, its identification takes time and multiple 
encounters, commodities lacking in many primary health care systems. Furthermore, the 
method of financing of care can affect the ease of a diagnosis of depression.23 Ironically, 
in more affluent settings, mental health may actually be less easily recognized and treated 
at the primary care level because of a tendency to over-rely on specialists. 
 Recognition of depression does not necessarily imply appropriate treatment. 
Patient non-compliance with medications is one of the most frequently cited reasons for 
treatment failure. Most often this is the result of intolerable side effects from the patient’s 
perception. Inadequate dosing by the physician also impedes proper treatment, since sub-
therapeutic regimens of appropriate antidepressants have not been found to alleviate the 
symptoms of depression. One study in Great Britain found that as many as 88% of 
prescriptions for older TCAs by primary care physicians were at doses below those 
outlined by consensus guidelines.31 Finally, health care systems can adversely impact the 
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treatment of depression by creating narrow formularies that do not cover appropriate 
therapies.   
 In contrast, many of these barriers are notably absent in the mental health sector. 
Since few patients present directly to a psychiatrist, there is less of an imperative to 
diagnose newly presenting mental disorders. Furthermore, if an undiagnosed patient were 
to present with a somatic form of depression, the psychiatrist’s eye would be better 
trained to recognize the disorder. Finally, psychiatrists enjoy the luxury of more time to 
spend with patients and lack the responsibility of concurrently evaluating physical 
diagnoses.  
 
A global context 
Fueled by an increasing recognition of the disability caused by mental illness, 
there has been a recent emphasis on understanding and promoting mental health at a 
global level. The provision of mental health care on an international scale poses unique 
challenges. Societal factors that adversely affect health and mental health are prevalent in 
many developing countries and include histories of upheaval and violence, poverty, 
unemployment, dislocation, inadequate education, gender discrimination, and political 
apathy. Furthermore, many countries lack or fail to mobilize adequate resources for 
medications, counseling, research, and training of health care providers. For example, it 
has been estimated that one third of the world’s population does not have access to basic 
psychotropic medications. 
Considerations relevant to understanding mental health care at the global level 
include differing forms of disease presentation, language, traditional medicine, and 
research priorities. Whether psychosocial distress is expressed as physical or 
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psychological symptoms varies according to culture and influences the health care 
provider’s ability to predict disease. Other factors that alter the form depression takes are 
the degree to which guilt is a component and the extent to which paranoid features mask 
depression.32  
The importance of culture is also evident in language. In contrast to many other 
cultures, it has been argued that western cultures prize language that differentiates among 
emotions, and that compartmentalization is favored over a holistic view of the body.32 A 
study in a Zimbabwean township demonstrated that women described depressive 
episodes as “thinking too much” or “deep sadness.” Somatization also played a role; 
grief, fear, or an insurmountable problem was often expressed as a heart complaint.12 
Another important consideration for many cultures is the reliance on traditional healers, 
who are often consulted before medical practitioners. Finally, research on the impact of 
mental health in developing countries is limited in scope, and western literature is not 
necessarily culturally transferable.  
       In their book on mental health in low-income countries, Desjarlais et. al. present 
a framework that highlights the challenges of mental health care in developing countries.4 
They posit that there are significant and reinforcing interactions among health problems, 
social pathologies, and exacerbating conditions. Depression, for example, is more 
prevalent and more difficult to confront in the presence of social pathologies such as 
substance abuse or violence and in the context of exacerbating conditions such as poverty 
or unemployment. Furthermore, the social problems and exacerbating conditions interact 
to intensify each other. Violent behavior often has its roots in conditions of 
unemployment or discrimination, and substance abuse frequently is tied to poverty or 
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limited education. When this triad of factors coexists, the result is an increase in 
vulnerability and a decline of welfare.  
 The challenge of global mental health lies in a dual threat of a surplus of 
devastating societal problems coupled with a lack of adequate resources; countries that 
confront the highest burdens of mental illness often have the fewest resources for its 
treatment. The urgency of the problem is reflected in recent “calls to action” for global 
mental health. In collaboration with the Department of Social Medicine at Harvard 
Medical School, WHO developed Nations for Mental Health, an initiative aimed at 
strengthening mental health policies and developing services that address specific country 
needs. WHO has also endorsed a global mental health strategy and initiated a global 
survey to compare the burdens of physical and mental disorders. For the first time in 
2001, the annual WHO World Health Day was devoted to raising awareness of mental 
health.  
 
The case of South Africa 
Despite having the strongest economy and most expansive resources in sub-
Saharan Africa, South Africa suffers from numerous societal problems typical of 
developing countries and rooted in the country’s history. The unique combination of 
social issues that foster mental illness and the potential resources to confront such illness 
makes South Africa an intriguing setting in which to study depression.  
 The burden of suffering incurred from mental illness in South Africa is intricately 
tied to the country’s political and social history. The apartheid system, developed in 1954 
to promote the separated development of races in South Africa, propagated 
discrimination and created societal disparities still present today. Apartheid was officially 
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abolished in 1990, and in 1994 the first national elections heralded the onset of black 
majority rule under Nelson Mandela and the African National Congress.  
 During the 1990s, South African society was in transition politically and socially. 
While the new government has been dedicated to reversing the inequities carved out 
under apartheid, imbalances in income, education, employment, housing, and health care 
remain and have not been solved in the short term. Furthermore, in the past decade, the 
AIDS epidemic has threatened the health and development potential of the nation.  
 The social and health challenges South Africa confronts are reflected in national 
statistics. South Africa is a middle income, developing country. Its population of more 
than 43,000 speaks 11 languages and carries an 81.8% literacy rate. Blacks comprise the 
racial majority and represent three quarters of the population. Ethnic minority groups 
include white (13.6%), Coloured (8.6%) and Indian (2.6%). The unemployment rate of 
30% reflects the lack of economic empowerment among disadvantaged groups and is 
linked to poverty and crime. It was estimated in 2000 that 50% of South Africans live 
below the poverty line.33  
 Health indicators in South Africa also reflect the impact of HIV/AIDS, an 
epidemic that claims the lives of 250,000 South Africans annually. It is estimated that 
nearly 20% of the adult population is infected with HIV, and approximately 4.2 million 
people live with the infection. Currently, the infant mortality rate is estimated to be 60.33 
deaths/1000 live births and the average life expectancy 48.09 years.33  
Evidence suggests that there is a substantial burden of mental illness in South 
Africa, and it is likely that the country’s political and social history plays a role. 
According to the “mental health model” of community psychology, many mental health 
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problems arise from political, economic, and societal ills.34 A study of Zimbabwean 
women showed that 73% attributed a specific social stressor to their depressive 
symptoms.12 Given the high rates of unemployment and poverty, it makes sense that 
mental illness is prevalent in South Africa. Furthermore, it has been argued that apartheid 
itself had a profound impact on mental health,35 and the system has even been labeled 
“psychiatrically pathogenic.”36   
The prevalence of clinical depression for South Africa has been reported to range 
from 14% to 49%.37 While specific studies differ in health care setting, instrument, and 
range of psychiatric disorders assessed, most prevalence estimates fall within this range. 
Two community-based studies that assessed mental disorders using two stages of 
screening both found over one-fifth of the population to be affected. In the rural town of 
Mamre in the Western Cape, point prevalence of psychiatric morbidity was found to be 
27.1%. Six percent of this group had anxiety disorders and 14% affective disorders, 
including dysthymia.36 Researchers in an African rural community in the province of 
KwaZulu Natal determined a weighted prevalence of generalized anxiety and depressive 
disorders to be 23.9%, with the following breakdown: 3.7% generalized anxiety, 4.8% 
major depression, 7.3% dysthymia, and 8.2% concurrent major depression and 
dysthymia.16 And a community study in nearby Lesotho that used DSM-III criteria found 
the rate of depression to be 12.4%.38 
 African studies have also demonstrated differences among gender, age, and 
education in depressed patients. One study conducted in two Ugandan villages showed 
that depression rates differed for women and men, with prevalence rates of 23% and 
14%, respectively.39 A more recent study of a group of low socioeconomic patients in 
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Pietermaritzburg, South Africa demonstrated a prevalence rate for depression of 28% and 
showed that depression correlated positively with age and negatively with education.15 
 Finally, analyzing depression in South Africa requires an understanding of the 
health care system. Under apartheid, medical services were racially segregated. Resource 
distribution was based on “population groups” and allocated by 14 separate departments 
of health. During this time, the health care system was concentrated in urban areas and 
funding favored tertiary care centers and private practices. In 1994 – after apartheid 
ended – 75% of South Africa’s health budget was spent on large hospitals and academic 
institutions and 46% was spent on the private sector that served only 19% of the 
population.40 
Mental health care was under the domain of psychiatry, but psychiatrists were 
scarce and unevenly dispersed. In 1989, the South African Medical and Dental Council 
registered 291 psychiatrists, or about 1 psychiatrist per 100,000 people.41 For 
comparison, it has been estimated that Western countries average 13 psychiatrists per 
100,000.42 It is thought that the South African figure is an overestimate of the actual 
services available, since some practitioners chose not to practice, served only private 
patients, or were localized in urban centers. By 1993, little had changed; it was estimated 
that of the 21,000 medical practitioners in South Africa, only 250 were psychiatrists.43 Of 
these few practitioners, only 7% were employed in non-metropolitan areas.44 This uneven 
distribution is demonstrated by the province of KwaZulu-Natal, a region with 20% of the 
South African population but only 7.4% of the public sector psychiatrists.5 Ironically, this 
province also has the highest prevalence of HIV.  
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 The logical solution to the scarcity of trained psychiatrists and their urban 
concentration was to shift care for mental illness to the primary care sector. This shift 
occurred in the context of the country’s transition to a democratic society and the creation 
of a nationalized health service based on a primary care approach. Specifically, the South 
African government aimed to increase the proportion of health care delivered in primary 
care settings, redistribute funds from hospitals and medical centers to community-based 
clinics, and increase the number of physicians who practiced in rural areas.45 While 
mental health care under apartheid had been delivered in a vertical system emphasizing 
chronic mental illness, the new system favored comprehensive integrated mental health 
care and used psychiatrists on a referral basis.  
 The transition to primary mental health care has posed numerous challenges that 
reflect common barriers to treating mental illness in primary care. Primary health care 
workers, already overburdened with responsibility, might lack the ability, inclination, and 
time to handle mental health care.34 When the busy primary care system does refer to a 
specialist, the psychiatrists in South Africa remain unevenly dispersed geographically. 
Low medication adherence is a problem that is likely widespread and was documented in 
the province of KwaZulu Natal.5 And despite the fact that depression and anxiety account 
for more than 80% of conspicuous psychiatric morbidity in African clinics,46 mental 
health efforts focus on psychotic disorders, often at the expense of addressing mood 
disorders.15 As a result of these obstacles, studies have indicated that 80% to 96% of 
mental health problems in certain African settings are undetected by health workers.47 
These numbers far exceed the accepted rate of missed psychiatric diagnoses of 50% and 
speak to a deficiency in the system.  
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There is optimism, however, that barriers to primary mental health care can be 
overcome. One expert calls for a shift in the paradigm of care, arguing that restructuring 
mental health care to be delivered at the primary care level will require system changes 
including health promotion, empowerment of patients, and medical care that assigns 
importance to the subjectivity of the illness experience.48 On a more practical level, it has 
been shown that short-term training of only a few hours can enhance a primary health 
care practitioner’s ability to care for mental health, and attitudes towards delivering such 
care also change. Addressing the issue of a shortage of time will likely require policy 
changes that increase the number of front- line generalists.34 Recent proposals have also 
focused on the use of primary mental health care nurses as an integral part of the delivery 
system.  
 There has also been a recent commitment to research at the policy and health care 
systems level in South Africa. One study assessed quality of mental health care in 
community- and hospital-based settings in three provinces of the country using 13 
standards of care.49 Another created a model for estimating the mental health service 
needs for people with severe psychiatric conditions and proposed a shift towards the 
development of rehabilitative staff.50 A group in Durban developed a framework for the 
provision of mental health care at the district level using a 5-tiered system that employed 
community psychiatric nurses as district mental health program coordinators.5 
 South Africa is an appropriate and instructive country in which to study primary 
mental health care based on a unique confluences of characteristics: a history of social 
upheaval that engenders mental illness, documented prevalence of psychiatric disorders, 
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long-standing barriers to the provision of care, and a mental health care system in 
transition, with policymakers actively engaged in the process of change.  
To our knowledge, the recognition and treatment of depression has not been 
studied in the Cape Flats region of South Africa’s Western Cape. (Appendix A) The 
primarily Coloured1 population lives in a community where poverty, high unemployment, 
violence, gang activity, and family disharmony are common. While a psychiatrist visits 
the clinic serving the area once a week, the primary care physician addresses most mental 
health problems. At the time of the study, the only class on antidepressants available was 
the TCAs, since SSRIs were not on the essential drug list for primary care. The social 
problems and mental health care delivery system are typical of many in the country and 
make the Cape Flats an appropriate setting in which to study depression in primary health 
care.  
                                                 
1 Use of the term “Coloured” originated in the South African Population Registration Act of 1950, now 
repealed, and connoted an individual with any one of a variety of racial origins who spoke either English or 
Afrikaans. It retains a descriptive value in post-apartheid South Africa, and its use in this context is not 
intended to impart any value judgment.  
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STATEMENT OF PURPOSE AND HYPOTHESIS 
 
This study will examine the recognition and treatment of depression at a 
community clinic in an underserved area of South Africa. We hypothesize that as in 
many primary care settings, recognition rates of depression are low and many depressed 
patients are not being appropriately treated. In the context of this analysis, we will 
explore the following topics: 
1) Physician prescribing patterns of antidepressants 
2) Determinants of depression 
3) Somatization of disease 
4) Cultural dimensions of disease 
5) Implications for South Africa and global mental health 
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METHODS 
 
Research site 
 The cohort was drawn from a group of patients visiting their primary care 
physicians at the Lotus River Community Health Centre (LRCHC) between June 18 and 
July 21, 1998. The community health center, located in the Cape Flats region of South 
Africa’s Western Cape (Appendix A), is a state clinic that provides free health care to a 
community of predominantly low socioeconomic status. It is one of forty such clinics that 
serves the Cape Town region. At the time of the research, the clinic was staffed by three 
full-time and four part-time physicians; each full time physician saw on average 45 
patients per day. The catchment population of the Cape Flats region is predominantly 
Coloured (of mixed ancestry). In 1999, more than half (55%) of the population attending 
the clinic was unemployed.51 The most frequent reasons for consultation at the clinic in 
1999 were cough, headache, and lower back pain, and the most common diagnoses were 
hypertens ion, acute upper respiratory tract infection, asthma, and osteoarthritis.51 
Antidepressants available to patients visiting the clinic included amitriptyline and 
imipramine. These medications were dispensed in one-month increments.   
 
Instrument 
Prevalence of mental disorders was determined by administration of PRIME-MD 
(Primary Care Evaluation of Mental Disorders), a diagnostic instrument specifically 
designed to diagnose mental disorders in a primary care setting. Sensitivity and 
specificity of a self-administered version of PRIME-MD called Patient Health 
Questionnaire were found to be 75% and 90%, respectively, and overall accuracy was 
found to be 85%.52 Of more than 1000 patients evaluated at four primary care sites, those 
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who had a PRIME-MD diagnosis showed greater functional impairment after correction 
for potential confounders.53 The instrument has been validated in numerous populations, 
including 3000 obstetric-gynecologic patients,54 patients undergoing radiation therapy,55 
and American Indians at an Indian Health Service urban clinic.56 In addition, PRIME-MD 
has been tested internationally in Spain,57, 58 Germany,59 Denmark,60 and Poland.61 
PRIME-MD is composed of two sections. The one-page Patient Questionnaire 
consists of 25 yes/no questions intended to screen for five diagnostic areas and one 
question pertaining to overall health perception. Although the screening portion of the 
instrument is intended to be self-administered by the patient, we chose to verbally 
administer the questionnaire because of varying literacy rates among patients. Positive 
answers in certain diagnostic areas trigger the administration of specific modules within 
the Clinician Evaluation Guide; these modules include mood disorders, anxiety disorders, 
somatoform disorders, eating disorders, and alcohol abuse and dependence disorders.  
For the purposes of this study, the alcohol and eating modules of PRIME-MD 
were excluded. In addition, the presence of bipolar disorder was not assessed, nor were 
depression or anxiety due to physical disorder, medication, or other drug. The physician 
who saw the patient on the day of the interview was responsible for completing the 
somatoform module. Additional data collected beyond that in PRIME-MD included age, 
gender, race, employment status, marital status, perception of health, and history of 
prescription of an antidepressant. 
 
Design  
A random sample of patients presenting to the clinic was invited to participate 
according to the following protocol. Patient at the clinic were sorted to see particular 
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physicians upon arrival to assure continuity and even workload. Each day interviews 
were conducted, every fifth patient visiting the clinic was selected to be interviewed 
according a sequential number attached to his or her chart. Patients for two physicians 
were followed on a given day. Data was collected by the author of this study and by one 
other researcher, and interviews were conducted in a private setting prior to the physician 
visit.  
Eligibility criteria included a minimum age of 18 and the ability to speak English. 
Patients selected to be interviewed who met these criteria were informed of the nature of 
the research and the time commitment of ten to twenty minutes involved. In addition, 
they were presented with an information sheet detailing the goals of the study (Appendix 
B). Verbal informed consent was obtained prior to the beginning of the interview. For 
those patients who declined participation, the patient with the next sequential number on 
the chart was asked to participate. A total of 222 patients were interviewed. Approval was 
obtained from the Yale University School of Medicine Human Investigation Committee 
and from the University of Cape Town Ethics Committee. 
Beyond the pre-determined eligibility criteria, patients were excluded from the 
study after completion of the interview if they were unable to thoughtfully or completely 
answer the questions posed, as determined by the interviewer. Three patients were 
excluded from the analysis because of lack of English language skills not detected in the 
initial screen (two patients) or lack of understanding of the interview secondary to a 
neurological disorder (one patient). A sample of 219 patients was used in the final 
analysis. To reduce variability in administration of the instrument, we limited the number 
of interviewers to two, and both interviewers conducted mock interviews with a 
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physician from the clinic prior to data collection to ensure cultural competency and 
consistency of administration of PRIME-MD and of interpretation of patient responses. 
To avoid recall bias when asking the patient about past TCA prescriptions, an actual 
tablet of amitriptyline and of imipramine were displayed as examples.   
 While diagnosis of mood and anxiety disorders could be determined by 
administration of PRIME-MD alone, determination of a somatoform disorder 
necessitated the expertise of a physician. If a patient had experienced three or more of the 
somatic symptoms screened for in PRIME-MD, the chart was flagged for follow-up by 
the appropriate physician, who would determine whether or not the symptoms could be 
explained by a medical condition.  
 Chart review was conducted the day the patient was interviewed after the patient 
had visited the pharmacy. Prescription of a tricyclic antidepressant (either amitriptyline or 
imipramine) was documented for that day and for any past visits. Information regarding 
rationale behind antidepressant prescription was not available. 
 
Data analysis 
 Prevalence data was generated using the PRIME-MD algorithm. Raw data was 
discarded for a limited number of reasons. If perception of overall health fell between 
two categories (for example, “fair/good”), that observation was excluded from analysis. If 
data from patient interviews and from chart review conflicted concerning past 
prescription of a TCA, the data from the chart was used to document past TCA use. 
Several new variables were generated to aid analysis. The continuous age variable was 
converted to an ordinal variable consisting of five age categories. A symptom count 
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variable served as an alternate indicator of somatization. A summary pain variable 
included any patient that had responded positively to back pain, joint pain, or headache. 
 
Statistical analysis 
 Statistical analysis was performed using Intercooled Stata 6.0. The student’s t test 
was used to assess the relationship between depression status and age. A test of 
proportions compared age distribution and health perception among depressed and non-
depressed patients. Chi-square analysis was used to determine the significance of 
correlations between dichotomous variables, including antidepressant prescription and 
depression. Multiple logistic regression analysis was employed to assess the independent 
effect of several independent variables on the outcomes of either TCA prescription or 
depression. An events to variable ratio of greater than 10 was sought for each model. 
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RESULTS 
Demographics 
 Demographic characteristics of the cohort are summarized in Table 1. The 
average age was 51 years (SD 17). Of all the patients interviewed, 67% were female 
(95% CI 61,73), 29% were employed (95% CI 23,35), and 45% were married (95% CI 
39,52). Health perception was skewed towards worse overall health, with 14% reporting 
health as excellent, 16% very good, 32% good, 28% fair, and 10% poor. Twelve percent 
of patients interviewed received a TCA on the day of their visit (95% CI 8,17), and 18% 
of patients had been prescribed a TCA sometime in the past (95% CI 13,23). Of the 25 
patients prescribed a TCA on the day of their visit, seven had never before taken one.  
 
 All Depressed Non-depressed p MDD Non-MDD p 
 N=219 N=70 N=147  N=29 N=189  
Age (SD) 51 (17) 44 (16) 55 (16) <.001 47 (12) 52 (17) .0833 
     18-25 9.59 20 4.76 .0004 6.90 9.52 .6481 
     26-40 15.98 17.14 14.97 .6801 24.14 14.81 .2029 
     41-55 31.05 37.14 28.57 .2032 48.28 28.57 .0330 
     56-70 29.68 22.86 32.65 .1391 20.69 31.22 .2485 
     Over 70 13.7 2.86 19.05 .0012 0 15.87 .0209 
Female 67.12 77.14 61.9 .0026 72.41 66.67 .539 
Employed 29.22 32.86 27.89 .453 27.59 29.1 .867 
Married 45.21 37.14 48.98 .101 44.83 45.5 .946 
Health (SD) 2.97 (1.19) 2.57 (1.13) 3.15 (1.18) .003 2.41 (1.34) 3.06 (1.15) .004 
     Excellent 14.42 10.77 16.31 .2946 14.81 14.44 .9593 
     Very good 15.87 4.62 20.57 .0033 3.7 17.78 .0625 
     Good 31.73 29.23 33.33 .5576 14.81 34.44 .0413 
     Fair 27.88 41.54 21.28 .0025 40.74 25.56 .0995 
     Poor 10.1 13.85 8.51 .2395 25.93 7.78 .0036 
Visit TCA 12.32 19.7 8.82 .028 25 10.34 .029 
Past TCA 17.92 26.87 13.99 .024 37.93 14.84 .003 
 
MDD=major depressive disorder, SD=standard deviation, TCA=tricyclic antidepressant 
Standard deviation of mean in parentheses. P values derived from student’s t test (for continuous age variable), test of 
proportion (for age and health sub-categories), and chi square analysis (all other p values). All other data represents 
percentages. Health rated on a scale of 1 to 5 with 1 being poor and 5 being excellent. P values of <.05 shown in bold.  
 
Table 1: Characteristics of depressed patients 
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Characteristics of patients stratified by depression status are also summarized in 
Table 1. Patients who met diagnostic criteria for any depressive disorder (major 
depressive disorder, dysthymia, minor depression, or partial remission of major 
depression) are included in the column labeled “Depressed.” Those categorized as Non-
depressed did not meet criteria for any depressive disorder based on PRIME-MD 
screening.  
Depressed patients tended to be younger than non-depressed by more than ten 
years, with an average age of 44 and 55 years, respectively (p<.001). Figure 1 shows 
depressed patients stratified by age group. Two age groups – the youngest and the oldest 
– show statistically significant differences in rates of depression. Twenty percent of 
depressed patients were in the 18-25 age group, compared to only 5% of non-depressed 
patients. This difference in proportion is statistically significant (p<.001). The 
proportions of patients who were depressed in the over 70-age group also show a 
statistically significant difference (p<01). 
 
Figure 1: Stratification of depression by age 
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Depressed patients also differed according to gender. Females comprised 77% of 
depressed patients compared to 62% of non-depressed patients (p=.0026). Employment 
status was similar (33% vs. 28%, p=NS). There was a trend for depressed patients to be 
unmarried (37% vs. 49%, p=.10)  
Patients who were depressed tended to have a more negative perception of their 
overall health than non-depressed, as shown in Figure 2. Eleven percent of depressed 
patients considered themselves to be in excellent health, 5% in very good health, 29% in 
good health, 42% in fair health, and 14% in poor health. The overall difference in health 
perception between depressed and non-depressed patients was significant according to 
chi square analysis (p=.003). When separated into individual health brackets, two groups 
showed statistically significant differences. The difference between the percentage of 
depressed and non-depressed patients who considered themselves to be in very good 
health was significant (p=.0033) as was that for fair health (p=.0025). It is possible that 
other health categories might have attained statistical significance were the sample sizes 
larger. 
Figure 2: Stratification of depression by health perception 
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With several exceptions, the trends for major depressive disorder parallel those 
for generalized depression. There was a trend for patients with major depression to be 
younger (p=.083). The major depression group was equally likely to be employed (28% 
versus 29%) and to be married than the group without major depression. The trend of 
worse perception of overall health seen for depressed patients was also present for 
patients suffering from major depression (p=.004). 
 In summary, the significant demographic characteristics for depressed patients 
include younger age, female gender, and worse health perception. Patients with major 
depression also had a worse perception of their health but did not differ significantly from 
those unaffected in terms of age, gender, employment, or marital status.  
 
Somatization 
 The assertion that psychological disorders often present as somatic complaints 
was substantiated in this study. Depressive disorders correlated strongly with individual 
somatic symptoms, as indicated by the results of the chi-square analysis outlined in Table 
2. It is clear from the data that every physical symptom screened for was more common 
amongst depressed patients, and that most of these correlations attained statistical 
significance. For example, 40% of depressed patients were bothered by chest pain 
compared to 21% of non-depressed and 27% overall (p=.003). With the exception of 
menstrual irregularities, fainting, and GI symptoms, no p value exceeded .02.  
Exploring mean symptom counts further validates the link between depression 
and somatic symptoms. While the mean symptom count approached 4.5 for all patients, 
depressed patients experienced on average nearly 6.5 symptoms (p<.001), and patients 
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with major depression averaged more than 7 (p<.001). The relationship between 
symptom count and depression status is depicted graphically in Figure 3.  
Figure 3: Symptom count and depression status 
 
 
 All Depressed Non-depressed p MDD Non-MDD p 
 N=219 N=70 N=147  N=29 N=189  
Stomach 21.00 35.71 13.61 <.001 37.93 17.99 0.013 
Back 43.84 57.14 38.10 0.008 65.52 40.74 0.012 
Joint 53.88 67.14 47.62 0.007 65.52 52.38 0.186 
Menstrual 13.61 20.37 9.89 0.077 28.57 11.11 0.031 
Sex 5.94 11.43 3.40 0.02 17.24 4.23 0.006 
HA 51.60 70.00 42.18 <.001 72.41 48.15 0.015 
CP 27.40 40.00 21.09 0.003 48.28 23.81 0.006 
Dizziness 26.94 38.57 21.09 0.007 48.28 23.81 0.006 
Fainting 5.05 5.71 4.79 0.774 3.45 4.79 0.749 
Palpitations 26.48 47.14 15.65 <.001 55.17 22.22 <.001 
SOB 35.16 51.43 27.21 <.001 65.52 30.69 <.001 
GI 23.29 24.29 21.77 0.678 31.03 22.22 0.297 
Nausea 16.44 32.86 8.84 <.001 34.48 13.23 0.004 
Fatigue 57.34 84.06 44.22 <.001 96.43 51.32 <.001 
Sleep 42.01 62.86 31.97 <.001 75.86 36.51 <.001 
        
Mean sx count 4.45 6.43 3.48 <.001 7.34 3.99 <.001 
 
MDD=major depressive disorder, HA=headache, CP=chest pain, SOB=shortness of breath, GI=gastrointestinal, 
sx=symptom. A positive response indicated pain or irregularity in the specified area. 
P values from chi square analysis. All other data represents percentages. P values of <.05 shown in bold.  
 
Table 2: Somatic symptoms according to depression status  
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Prevalence and comorbidities 
 Prevalence rates of psychiatric disorders are summarized in Table 3. The overall 
prevalence of depressive disorders was 32% (N=70). Within this category, 13% were 
diagnosed with major depression (N=29), 12% with partial remission of major depression 
(N=25), 14% with dysthymia (N=29), and 23% with minor depression (N=51). 
Somatoform disorder was diagnosed in 27% of all patients interviewed (N=55), with 15% 
falling into the category of multisomatoform disorder (N=32, symptoms present for at 
least several years). A diagnosis of somatoform disorder required the presence of 3 or 
more symptoms. Anxiety disorders occurred with a frequency of 21% in this population 
(N=45). Six percent of patients suffered from panic disorder (N=13), 6% from 
generalized anxiety (N=13), and 12% from anxiety NOS (N=25).   
 
 
 All Depressed Non-depressed p MDD Non-MDD p 
 N=219 N=70 N=147  N=29 N=189  
Depressive disorder 32.26 100 - - 100 21.39 - 
     MDD 13.3 42.03 - - 100 0 - 
     Partial remission 11.57 36.76 - - 0 12.77 - 
     Dysthymia 13.62 43.94 - - 62.96 6.45 <.001 
     Minor depression 23.39 72.86 - - 96.55 11.70 <.001 
Somatoform disorder 26.57 47.76 15.94 <.001 57.14 21.91 <.001 
     Multisomatoform 15.46 28.36 9.42 <.001 35.71 12.36 .002 
     Somatoform NOS 11.11 19.4 6.52 .005 21.43 9.55 .064 
Anxiety disorder 21.33 43.75 11.03 <.001 65.38 15.14 <.001 
     Panic disorder 6.02 10.14 4.11 .083 20.69 3.74 <.001 
     General anxiety 6.16 14.06 2.07 .001 26.92 3.24 <.001 
     Anxiety NOS 11.85 23.44 6.9 .001 26.92 9.73 .011 
 
MDD=major depressive disorder, NOS=not otherwise specified 
P values from chi square analysis. All other data represents percentages. P values of <.05 shown in bold.  
 
Table 3: Prevalence of psychiatric disorders 
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Concurrent psychiatric conditions occurred frequently and suggest that patients 
with one disorder are at higher risk for others. Patients with major depression also met 
criteria for dysthymia more than half the time; 63% of patients with major depression met 
criteria for both diagnoses, while only 6% of patients free from major depression suffered 
from dysthymia. Of the patients who met criteria for at least one of the depressive 
disorders, nearly half also met screening criteria for somatoform disorder, compared to 
only 16% of non-depressed patients (p<.001). Over 40% of depressed patients were also 
diagnosed with an anxiety disorder, versus 11% of patients without depression (p<.001).  
The trend is even more striking when considering patients with major depression. Nearly 
60% of patients with major depression had a concurrent somatoform disorder and over 
65% suffered from an anxiety disorder.  
 
Antidepressant prescribing patterns 
 The primary objective of this study was to determine whether patients diagnosed 
as depressed by PRIME-MD were actually being recognized as such by their physicians. 
This question was assessed by examining the association between depression and 
prescription of an antidepressant. For the purposes of this study, the prescription of an 
antidepressant was used as a surrogate marker for a diagnosis of depression. The 
correlation of a diagnosis of depression and the receipt of a TCA was found to be 
statistically significant, indicating that physicians were in fact recognizing patients who 
were depressed. This finding was true for both TCA prescriptions at the time of the visit 
and at prior visits. The association was also valid whether considering all depressive 
disorders or major depression alone. 
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 These results are summarized in Table 4. At the time of the visit, 20% of 
depressed patients received a TCA, while only 9% of non-depressed patients received 
one (p=.028). Past TCA receipt was also higher for depressed patients, with rates of 27% 
prior prescriptions versus 14% for non-depressed patients (p=.024).  
Patients with major depression were also more likely to receive a TCA than those 
without the disorder. Twenty-five percent of patients with major depression received a 
TCA at the time of their visit, compared to only 10% of patients without the illness 
(p=.029). At prior visits, 38% of patients with major depression and 15% of patients 
without it received an antidepressant (p=.003). 
 
 
 All Depressed Non-depressed p MDD Non-MDD p 
 N=219 N=70 N=147  N=29 N=189  
Visit TCA 12.32 19.7 8.82 .028 25 10.34 .029 
Past TCA 17.92 26.87 13.99 .024 37.93 14.84 .003 
 
MDD=major depressive disorder, TCA=tricyclic antidepressant 
P values from chi square analysis. All other data represents percentages. P values of <.05 shown in bold.  
 
Table 4: Correlation between depression and TCAs 
 
 
 Although there was a strong correlation between depression and treatment with a 
TCA, a small minority of patients who were depressed actually received an 
antidepressant. The ability of physicians to detect depression can be further explored by 
examining sensitivity and specificity (Fig. 4). The sensitivity of a TCA prescription – or 
the rate of prescribing TCAs when depression was present – was 20%. Conversely, the 
specificity – or lack of a TCA prescription when depression was absent – was 91%. The 
positive predictive value of a TCA prescription, or the proportion of those treated with a 
TCA who actually met criteria for depression, was 52%. The sensitivity and specificity of 
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tricyclic treatment for major depression were 25% and 90%, respectively. The positive 
predictive value was 28%. 
 
        Depression   
TCA + -   
+ 13 12 25
- 53 124 177
  66 136 202
 
            MDD   
TCA + -   
+ 7 18 25
- 21 156 177
  28 174 202
a b 
c d 
sensitivity = a/a+c; specificity = d/b+d; positive predictive value = a/a+b 
TCA=tricyclic antidepressant, MDD=major depressive disorder
 
Figure 4: Two-by-two tables for depression and TCA 
 
 Positive predictive values on the order of one third to one half suggest that 
physicians who prescribe TCAs are responding to more than depression.  In fact, the data 
indicate that many other variables correlate with antidepressant use. The results of this 
analysis are outlined in Tables 5 and 6.  
 The correlation between antidepressant use and major depression has been 
discussed. Receiving a TCA at the visit was also associated with minor depression 
(p=.009), and prior TCA use was correlated with both minor depression (p=.002) and 
dysthymia (p=.048). Other factors that significantly correlated with the prescription of a 
TCA at the visit included gender (p=.048), somatoform disorder (p=.001), anxiety 
disorders (p=.016) and panic disorder (p=.024). History of past TCA use was associated 
with gender (p=.015), somatoform disorder (p=.008), and anxiety disorder (p=.036). 
There was a trend for past TCA users to be female (p=.053).
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 Visit TCA   Past TCA  
  chi2 p  chi2 p 
Age group 3.8249 0.43  9.3269 0.053 
Gender 3.9185 0.048  5.9222 0.015 
Employment 0.4228 0.516  2.8285 0.093 
Marital 0.0165 0.898  0.0715 0.789 
Health 2.484 0.647  4.3612 0.359 
Depression 4.8446 0.028  5.1065 0.024 
     MDD 4.7767 0.029  9.0363 0.003 
     Partial remission 0.1836 0.668  9.9219 0.087 
     Dysthymia 1.0073 0.316  3.9148 0.048 
     Minor depression 6.8691 0.009  9.8811 0.002 
Somatoform 10.5864 0.001  7.0164 0.008 
     Multisomatoform 6.5783 0.01  3.1424 0.076 
     Somatoform NOS 2.5577 0.11  2.8194 0.093 
Anxiety 5.7835 0.016  4.4118 0.036 
     Panic 5.1164 0.024  1.4765 0.224 
     General anxiety 1.6971 0.193  1.8191 0.177 
     Anxiety NOS 1.5722 0.21  1.6512 0.199 
 
MDD=major depressive disorder, TCA=tricyclic antidepressant, NOS=not otherwise specified 
P values of <.05 shown in bold.  
 
Table 5: Chi-square analysis for antidepressant prescription patterns 
 
 
 Just as the diagnosis of depression bore a strong correlation to somatic symptoms, 
so too did the prescription of antidepressants. As outlined in Table 6, back pain (p=.009), 
joint pain (p=.019), headache, (p=.039) and sleep disturbances (p=.017) all were 
significantly associated with the prescription of an antidepressant at the visit. Past TCA 
use correlated significantly with back pain only (p=.007). The fact that TCA use 
correlated more strongly with somatoform disorder (see Table 5) than with any individual 
symptom indicates that a constellation of symptoms was most likely to trigger a 
prescription.  
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TCA=tricyclic antidepressant, HA=headache, CP=chest pain, SOB=shortness of breath, GI=gastrointestinal. A positive 
response indicated pain or irregularity in the specified area.  
P values of <.05 shown in bold.  
 
Table 6: Chi-square analysis of somatic symptoms and TCA prescription 
 
 
Multivariate analysis 
 Multiple logistic regression analysis was performed to determine the independent 
effect of several variables on the outcomes of either TCA prescription or depression. 
Examples of statistical output from STATA are included in Appendix C.  
 The factor that most strongly influenced TCA prescription was somatoform 
disorder. Having somatic complaints (regression coefficient=1.28) was more highly 
predictive than either depression (coefficient=.367) or gender (coefficient=.903). In fact, 
when the presence of somatoform disorder was taken into account, neither generalized 
depression nor major depression exhibited a statistically significant association with the 
prescription of an antidepressant. The only specific symptom that correlated with a 
prescription of a TCA was back pain (p=.045), and no single symptom approached 
somatoform disorder in strength of association. Interestingly, a summary variable for pain 
Visit TCA   Past TCA  
 chi2 p  chi2 p 
Stomach 0.0083 0.928  0.2179 0.641 
Back 6.7581 0.009  7.3607 0.007 
Joint 5.4646 0.019  1.9817 0.159 
Menstrual 1.9915 0.158  0.7286 0.393 
Sex 0.1873 0.665  0.7954 0.372 
HA 4.2564 0.039  2.356 0.125 
CP 0.0024 0.961  1.0938 0.296 
Dizziness 2.4043 0.121  1.0938 0.296 
Fainting 1.6432 0.2  0.6251 0.429 
Palpitations 1.6135 0.204  2.5897 0.108 
SOB 3.1851 0.074  1.774 0.183 
GI 0.3765 0.539  1.8672 0.172 
Nausea 0.2161 0.642  0.0681 0.794 
Fatigue 2.1673 0.141  2.1357 0.144 
Sleep 5.7358 0.017  1.3747 0.241 
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(any patient with back, joint, or headache symptoms) had only a minimal effect on the 
prescription of a TCA when included in a model with depression.  
 Multivariate analysis shows that gender is the strongest predictor for a history of 
past TCA use. In a model with gender, somatoform disorder, and anxiety, depression did 
not have a significant impact on the outcome of past TCA use. 
 The second dependent variable assessed by regression analysis – depression – was 
most strongly predicted by age, gender, somatoform disorder, and anxiety disorder. When 
symptom count was included in the model, it was also a strong determinant of depression. 
Although health perception did not significantly impact depression in a model with 
somatoform and anxiety disorders, it remained an important predictor in the absence of 
these disorders. The regression model most predictive of depression includes four 
somatic symptoms. In addition to age, gender, and somatoform disorders, depression was 
most strongly predicted by joint pain, palpitations, nausea, and fatigue. The presence of 
fatigue had the greatest relative impact on the whether a patient was depressed, with a 
coefficient of 1.86.  
In a regression model with major depression as the dependent variable, anxiety 
and somatoform disorders had the strongest independent effects on outcome. Symptom 
count was also substitutable for somatoform disorder in forecasting major depression.   
 
Validity of methodology 
 Several statistical analyses were conducted to assess validity of results. Rates of 
depression according to interviewer were found to be similar (31.53 versus 33.02%). 
Rates of TCA prescription varied from 0% (N=7) to approximately 17% (N=23), 
depending on the prescribing physician. The differences in prescription rates, however, 
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were not statistically significant. Physicians did vary considerably in terms of rates of 
somatoform diagnoses. Percentage of patients who met criteria for somatoform disorder 
according to diagnosing physician varied from 3% (N=31) to 75% (N=8) (p<.001). 
Interpretation of these differences is limited by a lack of power.  
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DISCUSSION 
 
 Depressive disorders are common and debilitating but are frequently overlooked 
in primary care settings. Exploration of this phenomenon has been largely confined to the 
western literature, and until recently there has been a paucity of meaningful research on 
global mental health care. This study addresses the characteristics and challenges of 
mental health care delivery in a sub-Saharan African setting by examining the question of 
whether depressive disorders are appropriately recognized and treated in a primary care 
South African clinic. Primary outcome measures included the prevalence of depressive 
disorders in the clinic and rates of detection of depressive disorders as indicated by 
prescription of a TCA. 
 
Recognition and treatment of depression 
 Physicians at the Lotus River Community Health Centre frequently detected 
depression when present, as indicated by the statistically significant correlation between a 
diagnosis of a depressive disorder and prescription of an antidepressant (p=.028). The 
ability of physicians to distinguish depressed patients from non-depressed during a 
regular office visit is also highlighted by differing crude rates of antidepressant 
prescription; depressed patients were more than twice as likely to be prescribed an 
antidepressant than were non-depressed.  
 Further analysis, however, reveals that although depression is being distinguished 
from lack of the disorder, the majority of depressed patients are in fact not prescribed 
TCAs. The sensitivity of TCA treatment was 20%. Unpublished data collected one year 
after this study from the same clinic indicates that psychiatric diagnoses were made in 
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only 7.6% of consultations, a figure significantly lower than predicted psychiatric 
prevalence in the region.51 
Although seemingly low, such detection rates are comparable to those in other 
primary care settings. Many detection rates fall within the 20% to 30% range, and rates 
are thought to be considerably lower in Africa. As indicated earlier, it is estimated that as 
few as 5% of patients with mental illness in sub-Saharan Africa are appropriately treated. 
Such universally low recognition rates point to a problem at the system rather than 
provider level.   
 The relationship between depression and antidepressant use raises further 
questions with practical implications. If sensitivity is low relative to an ideal, what factors 
are impeding the recognition of depression? As discussed earlier, recognition of 
depression in a primary care setting is traditionally challenging. Stigma of mental illness, 
subtle presentations often highlighting somatic symptoms, and limited physician time and 
training all contribute to this shortcoming. In this particular study, it is also possible that 
some patients identified as depressed by the physician were not prescribed an 
antidepressant. For example, one patient was offered a TCA but declined for fear of 
sleeping through nighttime violence; this patient would not have been reflected in the 
detection rate.  
 The fact that the positive predictive value of a TCA prescription for depression is 
only 50% suggests a converse scenario: that patients were prescribed TCAs for reasons 
other than depression. Underlying this issue is the versatility of TCAs. This class of 
antidepressant has been found to be efficacious in sleep disturbances and in disorders as 
varied as low back pain, peptic disease, fibrositis, headache, peripheral neuropathy, 
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rheumatoid disease, and irritable colon; one study found that 15% of prescriptions were 
for non-psychiatric conditions that were TCA-responsive.62 It is therefore possible – and 
probable – that physicians are prescribing antidepressants in response to symptoms other 
than depression. The fact that there was a significant association between the prescription 
of a TCA and pain or sleep symptoms makes it difficult to determine whether physicians 
are intending to treat somatic or psychological symptoms. 
 The results of the multivariate analysis help to clarify this question of physician 
motivations and suggest that physicians’ prescribing patterns do in fact reflect 
recognition of factors other than depressive symptoms. The regression model indicates 
that the strongest factor influencing whether or not a patient is prescribed a TCA is the 
presence of somatoform disorder. This association of somatoform disorder and TCA 
prescription is so strong that it essentially nullifies the correlation between depression and 
TCA prescription. The finding that physicians are prescribing antidepressants based on 
somatic symptoms reflects a striking convergence of mood and somatic symptoms and 
indicates a physician awareness of this occurrence.    
 Regression analysis also reveals that physicians are not responding to any single 
symptom but rather to the presence of a number of symptoms. No individual symptom 
impacts the outcome of TCA prescription as strongly as somatoform disorder. 
Somatoform disorder also predicts TCA prescription more strongly than sleeping 
disturbances or a summary variable encompassing joint pain, back pain, and headache. 
Thus, patients who have a constellation of nonspecific symptoms are the most likely to be 
recognized by the physician as deserving of an antidepressant.  
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 While prescription of a TCA at the time of the visit was influenced most strongly 
by somatic complaints, multivariate analysis indicates that past antidepressant use is most 
affected by gender. In a model assessing the relative impact of depression, gender, 
somatoform disorder, and anxiety, gender is in fact the only variable that remains 
significant. Conclusions based on this model, however, are limited by the fact that 
patients’ psychological and physical symptoms at the time of the prescription are 
unknown; gender is the only variable that remains unchanged over time. It is possible that 
physicians were responding to other factors that could not be documented at the time of 
screening.  
 The results of the chi-square analysis for specific depressive disorders are also of 
interest. Both major and minor depression significantly correlate with TCA use. This 
finding is consistent with the fact that these diagnoses include symptoms that are both 
concrete and current. It is also logical that a diagnosis of partial remission of major 
depression would not correlate well with a prescription of an antidepressant, since 
symptoms have largely abated and might not present as overtly.  
Interestingly, a diagnosis of dysthymia is not associated with a TCA prescription 
at the time of the visit, and its correlation with past TCA use approaches the limit of 
statistical significance. This finding might result from the nature of the disorder. 
Dysthymia by definition is chronic and presents in a more insidious manner than other 
depressive disorders. Furthermore, its long-term course might cause dysthymic symptoms 
to be identified as an individual’s baseline personality, rendering the disorder less easily 
recognizable.  
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The strongest correlation exists between major depression and history of a prior 
antidepressant prescription. It is unclear why this correlation is stronger than TCA 
prescription at the time of the visit, but it is possible that patients who have been long-
time sufferers of major depression and long-time users of antidepressants might have 
been more comfortable with and conversant about their symptoms during the screening 
interview and consequently met criteria for depression. 
An essential component of an appropriate response to depression is proper 
treatment, including medication selection and dose. At the time the research was 
conducted, the only antidepressant class available to patients covered by South Africa’s 
national formulary was the tricyclics. At Lotus River, amitriptyline was nearly 
universally used, usually at a dose of 25 or 50 mg per day. The fact that this dose is 
considered to be sub-therapeutic for the treatment of major depression raises the question 
of whether depressed patients were actually successfully treated.  
The efficacy of low-dose TCAs for depression remains under debate. While many 
evidence-based studies indicate that low doses are not effective, the majority of research 
focuses on major depression. Anecdotal evidence from the literature and from this study, 
however, suggests that low doses can be effective towards relieving symptoms of 
depression. During an interview conducted at Lotus River, one patient recounted his 
emotional state and the effect of amitriptyline: 
You know it felt like you were all alone in the world and nobody was interested in your 
troubles…it got so bad that most probably the people thought I was trying to take my own 
life…you know when you’re in a state like that you got no appetite and you can’t sleep at 
night and you lay awake the whole night thinking what is going to happen…everything was 
closing in on me…because I lost my job already now and because of this accident my 
shoulder was broken and I couldn’t move this arm at all. And then I thought to myself, now I 
can’t even work you know and that really put me in a state of depression…But I must say if it 
wasn’t for these panic tablets then I don’t know if I would have coped…It calmed me 
completely. After I’ve taken the tablets, it just calms me and I could be like a normal person, 
you know without worrying…it helped me right through this situation.63 
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Testimonies such as this patient’s suggest that antidepressant doses traditionally 
considered to be sub-therapeutic might in fact be conferring undetected benefit. The 
impact of low-dose TCA therapy for minor depression or dysthymia awaits further 
exploration. 
 
Determinants of depression 
While the primary objective of this study was to explore TCA prescription 
patterns, we also examined the determinants of depression. Understanding the common 
presenting features of a disorder can lead to the development of more sensitive and 
specific screening tools and improve rates of detection and treatment. In this group of 
patients presenting to a primary care South African clinic, depression was associated with 
being younger, female gender, worse perception of overall health, concurrent anxiety 
disorder, and the presence of somatic symptoms. 
 Although many studies have shown depression to increase with age, we found 
depression to be more common among younger patients. A widespread argument for 
depression’s association with age is that older people are often less optimistic and enjoy 
less social support, thereby lowering the threshold for depression. It has been argued that 
older South Africans might be more prone to depression because they witnessed and 
lived through apartheid.15 However, our findings that young people are more likely to be 
depressed are consistent with the fact that the young are uniquely positioned to be 
adversely impacted by apartheid’s legacy of societal problems. Unemployment and 
violence endemic in many areas of Africa particularly impact the young, and challenges 
are exacerbated while raising a family. Furthermore, it is the young population that is 
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disproportionately affected by HIV/AIDS, whether in the workplace, during pregnancy, 
or within communities. While older South Africans are certainly not immune to the 
epidemic, it is the young who have never known a time free of the stigma, devastation, 
and daily uncertainty engendered by HIV/AIDS. 
 Being female also appears to predispose to depression, and this finding has been 
substantiated in both the western and African literature. Another distinctive feature of all 
depressed patients is that they perceive themselves to be in relatively poor health. The 
fact that this correlation holds for all depressive disorders implies that depression that is 
minor or chronic in nature can in fact lead to substantial functional impairment. 
Furthermore, there was a striking correspondence between major depression and 
dysthymia, indicating that many patients suffer from acute on chronic forms of 
depression and likely suffer greater distress.   
There was also a statistically significant association between depression and 
anxiety disorders, a finding that has been confirmed in other studies. This concordance 
raises the question of whether the presence of both disorders enhances or detracts from a 
physician’s ability to accurately diagnose either one. It is possible that a suspicion for one 
psychiatric disorder might encourage a physician to screen for others, especially since 
some of the therapeutic options overlap. Conversely, the presence of nonspecific and 
persistent symptoms indicative of two separate disorders might avert rather than attract 
physician attention, especially if trying to assign a unifying diagnosis.  
  The correlation between somatoform disorder and depression was also significant 
and reflects that fact that depression often heralds itself with somatic rather than 
psychological symptoms. In addition to somatoform disorder, 12 of 15 symptoms 
  
52
correlated positively with depression. The only two symptoms that did not correlate with 
a diagnosis of depression were ones that were concrete and that could be easily 
characterized as present or absent: fainting and GI symptoms (specifically patients were 
asked whether they had constipation or diarrhea). Data collected from the same clinic in 
1999 reinforces the importance of somatic presentations. Despite predicted regional 
psychiatric prevalence rates in the 20% to 30% range, only 3.4% of reasons for 
presenting to clinic were documented as psychiatric in nature.51 Community anecdotal 
evidence suggests that vague physical complaints often mask psychological symptoms 
during the medical encounter.  
 When assessing the independent effect of variables on depression through 
multivariate analysis, age, gender, somatoform disorder, and anxiety disorder were most 
predictive. When somatoform and anxiety disorders were excluded from the model, 
health perception remained a significant predictor of depression. Moreover, specific 
symptoms – joint pain, palpitations, nausea, and fatigue – were more highly predictive of 
depression than somatoform disorder alone. Of these, fatigue was the most robust 
predictor of depression, and interestingly can be classified as both a physical and 
psychological symptom.    
 The identification of predictors for depression can be used to develop screening 
tools. Given uniformly low detection rates, numerous groups have attempted to develop 
simple and efficient screening methods for depression. One group proposed screening by 
the 2-item PRIME-MD depression screen followed by evaluation of four depressive 
symptoms (sleep disturbance, anhedonia, low self-esteem, and decreased appetite).64 
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Another highlighted the presence of recent stress, five or more physical symptoms, and 
poor health as useful indicators of depression.65 
 For this group of patients, the presence of numerous ill-defined symptoms without 
immediately apparent medical cause should serve as a collective red flag for the primary 
care physician. In addition to an unusual number of symptoms, the health care worker 
should also be alerted to any specific symptoms that are subjective and chronic. In this 
study, joint pain, palpitations, nausea, and fatigue were most strongly correlated with 
depression; however, the non-specific nature of these symptoms makes them less reliable 
as screening tools.  
 Interestingly, anxiety is the strongest predictor of depression in the model but is 
not clinically useful as a diagnostic tool. Screening tools are meant to rule out certain 
disorders in a time-efficient manner. Although anxiety often co-presents with depression, 
diagnosing anxiety requires as detailed and lengthy an interview as diagnosing 
depression. Thus the practical applications of anxiety as a predictor of depression are 
limited. 
 Finally, the patient’s perception of his or her health should be considered for use 
as a screening tool for depression. Although a negative health perception was not the 
strongest predictor of depression in the regression model, its relative effect increased 
when included in a model with variables that could be easily assessed in a primary care 
setting, e.g. a model that excluded anxiety. Health perception can be conceived of as a 
summary measure of the presence of somatic and psychological symptoms and can be 
screened for quickly and objectively in a primary care setting.  
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Prevalence estimates 
 Direct comparison of prevalence studies for depressive disorders is difficult 
because of a lack of homogeneity. Studies differ in terms of culture, patient population, 
sociodemographic factors, diagnostic instrument, and methodology. Furthermore, some 
studies focus on a subset of depressive disorder while others include all forms of mental 
illness.  
 Given these limitations, the prevalence figures determined in this study are 
consistent with those reported elsewhere. The overall depression rate of 32% is somewhat 
higher than the range reported for psychiatric diseases in international settings, between 
17 and 24%.10 The major depression rate of 13% is comparable to the rate of 10% 
frequently endorsed by the WHO.7 Over 40% of patients diagnosed with depression in 
this study also had an anxiety disorder. This finding reflects a common trend of 
coexisting depression and anxiety presenting in primary care settings.  
 
Limitations 
Factors that might have influenced the reliability of diagnosing mental disorders 
include the instrument, interviewers, and physicians. Although PRIME-MD has been 
validated in many international settings, it has not specifically been tested for sub-
Saharan Africa. The language and concepts implicit in the questionnaire were discussed 
with local physicians to assure the highest degree of patient understanding, but cultural 
barriers might have remained. Testing for validity in South Africa would entail a two-
stage study using a standardized instrument or set of guidelines for comparison.  Our 
findings might also have been biased by false positive or false negative results since 
neither the sensitivity nor specificity of PRIME-MD is 100%.  
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The utilization of two interviewers could also have introduced variability in 
administration of the instrument or interpretation of responses. The fact that depression 
rates were nearly identical for the two interviewers screening with PRIME-MD suggests 
consistency, but this conclusion relies on the assumption that the groups of patients 
interviewed by the two researchers actually had similar rates of depression. Finally, the 
diagnosis of somatoform disorder was contingent on a physician’s ruling out organic 
cause of symptoms, but there was significant variation in the rates of somatoform 
diagnoses among physicians. It is difficult to determine whether this reflects differences 
in the actual rates of somatoform disorder in patients presenting to different physicians or 
differences in physician threshold for diagnosing the disorder.  
 Several factors might have affected data on detection of depression. First, a 
prescription of a TCA was used as a marker for a diagnosis of depression, yet physicians 
prescribed antidepressants for reasons other than depression, and a TCA might not have 
been prescribed in every case of depression. The TCA was used as a marker because it 
was the primary means of treating depression and was the most reliable marker available. 
Chart notes did not consistently include rationales for treatment, and one physician 
charted in Afrikaans. Second, it is possible that administering PRIME-MD to patients 
primed them to mention symptoms to their doctor that would otherwise not have been 
elicited. It is difficult to predict the effect of a pre- interview, however since patients were 
asked about a wide range of issues including both somatic and psychological symptoms. 
Third, the determination of past receipt of a TCA might have been imperfect because 
chart review preempted anecdotal information from the patient. Chart review was 
employed as a default measure to reduce the possibility of recall bias, especially if the 
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patient had been on an antidepressant in the distant past. There remains, however, the 
possibility that a patient without chart documentation had in fact been on a TCA 
prescribed by another caregiver.  
 
Implications 
 
1) Somatization 
 The data gathered in the study strongly suggest that depression in this setting is 
presenting as a cluster of nonspecific physical symptoms. This result is consistent with 
the fact that mental illness can present differently in different cultures and countries, and 
that somatization is especially common in African settings. The presentation of mental 
illness as somatic symptoms is traditionally perceived to be an impediment to detection, 
propelling physicians to consume energy and resources chasing physical etiologies of the 
symptoms. In this clinic, however, it was shown that physicians prescribing TCAs are 
primarily responding to somatic rather than psychological symptoms.    
The unexpected and welcomed finding, then, is that physicians who appeared to 
be responding to a trigger other than depression in their prescription patterns were 
actually responding to depression in an alternate form. While previous studies suggest 
that somatized depression might be a barrier to diagnosis, we have found that in this 
South African clinic, somatization may in fact be what is recognized and treated by 
physicians who are culturally sensitive to their environment. By prescribing 
antidepressants to poly-somatizing patients, South African physicians are paradoxically 
interpreting somatic symptoms as a guide rather than an impediment to recognizing 
depressed patients. 
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2) Social, cultural and political considerations 
 As suggested in the discussion of somatization, cultural variations can affect 
disease presentation, medication compliance, and interpretation of research, to name just 
a few areas. An analysis of mental health care in South Africa underscores the 
importance of taking into account social, cultural, and political forces when considering 
disease. Social factors such as poverty and unemployment dramatically influence mental 
health disorder prevalence and ability to access medical care. Language specific to a 
culture affects understanding of disease – consider whether a problem with “nerves” 
implies an anxiety or a mood disturbance, or none at all. Widely accepted stigma can bar 
individuals from care or treatment and can demoralize communities. And political 
commitment is reflected in the breadth of health coverage and formularies and in the 
financing of the public health sector. 
 While much research has been devoted to explaining the barriers to diagnosing 
depression in the primary care sector, few studies have compared these barriers across 
different cultural settings. One formidable barrier to care is lack of adequate access to 
appropriate medication, a problem often linked to culturally specific determinants. At the 
time of this study, South Africa’s national health insurance did not cover SSRIs. 
Tricyclics were often prescribed at sub-therapeutic doses to avert side effects that often 
caused noncompliance. The fact that the most well tolerated antidepressants were not 
available to South Africans reflects limitations in the South African health care system 
and a lack of political commitment at the national level to prepare an inclusive formulary. 
Within the past several years, fluoxetine (an SSRI) has become available to all 
community health centers in the Cape Town region at the cost of 75 mg of a TCA.  
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Positive changes such as this one underscore the importance of political commitment in 
mental health care.  
 
3) Implications for South Africa and global mental health 
 The results of this study can help to address issues in mental health care specific 
to South Africa. The impressive somatization of depression observed has implications for 
screening. While physicians in this clinic were cognizant of the somatic presentation of 
depression as indicated by their prescribing patterns, South African health care 
practitioners not already aware of this trend must be trained to recognize that somatic 
symptoms can in fact represent depression. Structuring the system around this conclusion 
might call for significant reorganization, such as adding front-line staff or training 
community mental health nurses to pre-screen for the presence of somatic symptoms 
prior to the physician visit.  
 A second consideration specific to South Africa is the interaction between mental 
illness and HIV/AIDS. Being HIV positive has been linked to depression, and South 
Africa is estimated to have the highest number of HIV positive individuals of any 
country. This fact alone implies that the prevalence of depression and other mental illness 
is likely significantly higher than observed. Like depression, HIV is stigmatized, and the 
effects of discrimination might exacerbate psychological distress. Moreover, being 
depressed in the presence of HIV can affect quality of life and disease progression. 
Maintaining health in the face of HIV depends on a dutiful adherence to a complicated 
medical regimen. While most HIV positive individuals in South Africa do not yet have 
access to HAART (highly active antiretroviral therapy), depression would likely hinder a 
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patient’s ability to handle the medications when they do become available. Presently, 
depression is likely to affect adherence to prophylactic medications.  
This study confirms prior findings that mental illness is common across national 
boundaries and that interventions should be tailored to specific settings. While the 
experiences of South Africa might apply to other developing countries or to underserved 
regions of any country, it is important to consider the specific setting and local influences 
when examining burden of disease or developing policy. This study was conducted in a 
single clinic with a relatively homogenous catchment population. The group studied 
represented a single race – Coloured – that accounts for only 8% of South Africa’s 
population. The social problems experienced by this group might reflect those in other 
countries and cultures, but it cannot be assumed that the conclusions drawn are 
necessarily applicable to other settings. Rather, other countries must develop analogous 
research protocols and policy that reflect specific social structures, patient attitudes, 
provider backgrounds, and health care systems. 
 
Conclusion 
 Mental illness in developing countries is common, and statistics likely vastly 
underestimate the true burden of disease. Physicians are limited in their ability to 
diagnose mental illness – particularly in its somatized form – and detection rates are 
consistently low. The consequences of mental illness far outreach the direct effect on an 
individual: mental disorders are costly in terms of global human distress and in terms of 
national productivity and health. Ironically, this group of disorders is more costly to 
struggling nations that simultaneously confront formidable social problems and limited 
resources. Mental health problems can redirect the course of an individual’s life and are 
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predicted to escalate globally. For these reasons, policy around mental illness should be 
thoughtfully and rapidly formulated, even in the setting of conflicting priorities. Without 
this degree of commitment, we will invite a decline in global well-being in the years 
ahead. 
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APPENDIX A: MAPS 
 
South Africa 
 
 
 
 
 
 
 
 
 
 
 
 
 
From http://www.cia.gov/cia/publications/factbook/geos/sf.html 
 
 
The Cape Peninsula 
 
 
 
From http://www.cape-town.net/html/mappenin.html
  
68
APPENDIX B: PATIENT INFORMATION SHEET 
 
 
 
 You are invited to participate in a study of the diagnosis and treatment of 
depression in primary care health clinics. The purpose of the study is to determine how 
many patients who come to clinics like Lotus River are depressed, and to determine how 
they are treated for depression. We would also like to talk to you about how you feel 
about the medical care you have received at this clinic, and about your treatment for 
depression if you have received any. You have been selected at random because you 
came to Lotus River Community Health Centre today.  
 
 Participation in the study will involve a fifteen-minute interview that includes 
questions about your recent health and activity level, and about how happy you have 
been. We will also ask whether you have been diagnosed or treated for depression in 
the past. Some patients who have been diagnosed with depression or have been treated 
with antidepressants might have a longer interview (over an hour) about any stresses in 
their lives and about their feelings concerning the treatment they have received. These 
interviews will be taped on a recorder so that we can make sure the information we 
obtain is accurate. We may ask you do the second longer interview at a later time.  
 
 The information we collect from this study will help us understand how 
depression is treated at this clinic. By determining how many patients are depressed, 
how many are treated, and whether the treatment is working, we can figure out whether 
there is some way to improve treatment and better care for depression in health care 
settings where there may not be a psychiatrist available.  
 
 With your permission, we would like to look at your medical record. All 
information that you share with us will remain completely confidential. Your name will be 
recorded so that we can access information in your medical chart but after that point 
your name or any other identifying information will not be used. There are no physical 
risks to this study. However, the time that it takes to conduct the interview may be 
inconvenient. This study will not affect your medical treatment in any way. You do not 
need to reply to any question that you feel uncomfortable answering.  
 
 Please feel free to ask us any questions that you might have about this research 
and your role as a participant.  
 
 Thank you very much for reading this sheet and for considering participating. 
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APPENDIX C: STATISTICAL OUTPUT 
 
 
STATA output displaying the logistic regression of visit TCA on depression, gender,  
and somatoform disorder.  
 
Logit estimates                                   Number of obs   =        196 
                                                  LR chi2(3)      =      13.43 
                                                  Prob > chi2     =     0.0038 
Log likelihood = -64.157196                       Pseudo R2       =     0.0948 
 
------------------------------------------------------------------------------ 
visit_tc |      Coef.   Std. Err.       z     P>|z|       [95% Conf. Interval] 
---------+------------------------------------------------------------------- 
depressi |   .3667654   .4930676      0.744   0.457      -.5996292     1.33316 
  gender |   .9026865   .5879178      1.535   0.125      -.2496113    2.054984 
somatofo |    1.27969   .4901979      2.611   0.009         .31892     2.24046 
   _cons |  -3.338076   .5841399     -5.715   0.000      -4.482969   -2.193183 
------------------------------------------------------------------------------ 
 
 
Figure 4: STATA output displaying the logistic regression of depression on age group, 
gender, somatoform disorder, and anxiety disorder  
 
Logit estimates                                   Number of obs   =        197 
                                                  LR chi2(4)      =      55.01 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -94.404129                       Pseudo R2       =     0.2256 
 
------------------------------------------------------------------------------ 
depressi |      Coef.   Std. Err.       z     P>|z|       [95% Conf. Interval] 
---------+------------------------------------------------------------------- 
age_grou |  -.4413942   .1698373     -2.599   0.009      -.7742692   -.1085192 
  gender |   1.207742   .4242458      2.847   0.004        .376235    2.039248 
somatofo |   1.221318   .3818549      3.198   0.001       .4728966     1.96974 
 anxiety |   1.584835   .4267969      3.713   0.000       .7483287    2.421342 
   _cons |  -1.067351   .6545869     -1.631   0.103      -2.350317     .215616 
------------------------------------------------------------------------------ 
 
 
Figure 5: STATA output displaying the logistic regression of depression on age group, 
gender, somatoform disorder, joint pain, palpitations, nausea, and fatigue  
 
Logit estimates                                   Number of obs   =        204 
                                                  LR chi2(7)      =      95.72 
                                                  Prob > chi2     =     0.0000 
Log likelihood = -80.556549                       Pseudo R2       =     0.3727 
 
------------------------------------------------------------------------------ 
depressi |      Coef.   Std. Err.       z     P>|z|       [95% Conf. Interval] 
---------+------------------------------------------------------------------- 
age_grou |  -.7874901   .1978674     -3.980   0.000      -1.175303   -.3996771 
  gender |   .8822751    .442929      1.992   0.046       .0141502      1.7504 
somatofo |   .8350391   .4215117      1.981   0.048       .0088913    1.661187 
   joint |   1.259086   .4388992      2.869   0.004       .3988596    2.119313 
    palp |    1.18413   .4336542      2.731   0.006       .3341837    2.034077 
  nausea |    1.55165   .5012029      3.096   0.002       .5693099    2.533989 
 fatigue |   1.868995   .4715866      3.963   0.000       .9447018    2.793287 
   _cons |  -1.890459   .7249946     -2.608   0.009      -3.311423    -.469496 
------------------------------------------------------------------------------ 
 
